Golyszny M, Zielinski M, Paul-Samojedny M, Palasz A, Obuchowicz E
AIMS Neurosci. 2022; 9(3):395-422.
PMID: 36329901
PMC: 9581731.
DOI: 10.3934/Neuroscience.2022022.
Michopoulos V, Perez Diaz M, Embree M, Reding K, Votaw J, Mun J
J Neuroendocrinol. 2014; 26(2):80-8.
PMID: 24382202
PMC: 3962807.
DOI: 10.1111/jne.12129.
Holmes A
Neurosci Biobehav Rev. 2008; 32(7):1293-314.
PMID: 18439676
PMC: 2561331.
DOI: 10.1016/j.neubiorev.2008.03.006.
Heisler L, Pronchuk N, Nonogaki K, Zhou L, Raber J, Tung L
J Neurosci. 2007; 27(26):6956-64.
PMID: 17596444
PMC: 6672238.
DOI: 10.1523/JNEUROSCI.2584-06.2007.
Hennig J, Opper C, Huwe S, Netter P
J Neural Transm (Vienna). 1997; 104(10):1027-35.
PMID: 9503255
DOI: 10.1007/BF01273316.
Influence of age on the GH response to sumatriptan administration in man.
Coiro V, Volpi R, Davoli C, Caffarri G, Chiodera P
J Neural Transm Gen Sect. 1995; 101(1-3):195-200.
PMID: 8695049
DOI: 10.1007/BF01271556.
Temperature, food intake, and locomotor activity effects of a 5-HT3 receptor agonist and two 5-HT3 receptor antagonists in rats.
Mazzola-Pomietto P, Aulakh C, Murphy D
Psychopharmacology (Berl). 1995; 121(4):488-93.
PMID: 8619014
DOI: 10.1007/BF02246499.
Complex effects of age and gender on hypothermic, adrenocorticotrophic hormone and cortisol responses to ipsapirone challenge in normal subjects.
Gelfin Y, Lerer B, Lesch K, Gorfine M, Allolio B
Psychopharmacology (Berl). 1995; 120(3):356-64.
PMID: 8524984
DOI: 10.1007/BF02311184.
Effect of acute and repeated administration of 5-HT1A receptor agonists on 5-HT release in rat brain in vivo.
Sharp T, McQuade R, Bramwell S, Hjorth S
Naunyn Schmiedebergs Arch Pharmacol. 1993; 348(4):339-46.
PMID: 7904048
DOI: 10.1007/BF00171331.
Neuroendocrine effects of sumatriptan.
Herdman J, Delva N, Hockney R, Campling G, Cowen P
Psychopharmacology (Berl). 1994; 113(3-4):561-4.
PMID: 7862876
DOI: 10.1007/BF02245240.
Time course of the effects of adrenalectomy and corticosterone replacement on 5-HT1A receptors and 5-HT uptake sites in the hippocampus and dorsal raphe nucleus of the rat brain: an autoradiographic analysis.
Tejani-Butt S, Labow D
Psychopharmacology (Berl). 1994; 113(3-4):481-6.
PMID: 7862863
DOI: 10.1007/BF02245227.
Effect of pindolol on the L-5-HTP-induced increase in plasma prolactin and cortisol concentrations in man.
Meltzer H, Maes M
Psychopharmacology (Berl). 1994; 114(4):635-43.
PMID: 7855226
DOI: 10.1007/BF02244995.
Effects of ipsapirone in healthy subjects: a dose-response study.
Kahn R, Trestman R, Lawlor B, Gabriel S, Davidson M, Siever L
Psychopharmacology (Berl). 1994; 114(1):155-60.
PMID: 7846198
DOI: 10.1007/BF02245457.
Drug-induced defaecation in rats: role of central 5-HT1A receptors.
Croci T, Landi M, Bianchetti A, Manara L
Br J Pharmacol. 1995; 115(1):203-9.
PMID: 7647978
PMC: 1908762.
DOI: 10.1111/j.1476-5381.1995.tb16340.x.
Effect of pindolol on the prolactin response to d-fenfluramine.
Park S, Cowen P
Psychopharmacology (Berl). 1995; 118(4):471-4.
PMID: 7568634
DOI: 10.1007/BF02245948.
Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis.
Sharp T, Bramwell S, Hjorth S, Grahame-Smith D
Br J Pharmacol. 1989; 98(3):989-97.
PMID: 2574066
PMC: 1854745.
DOI: 10.1111/j.1476-5381.1989.tb14630.x.
The effects of gepirone on neuroendocrine function and temperature in humans.
Anderson I, Cowen P, Grahame-Smith D
Psychopharmacology (Berl). 1990; 100(4):498-503.
PMID: 2157231
DOI: 10.1007/BF02244002.
Investigation of the mechanism(s) of 8-OH-DPAT-mediated inhibition of plasma insulin in spontaneously hypertensive rats.
Bouhelal R, Mir A
Br J Pharmacol. 1990; 100(1):173-9.
PMID: 2142614
PMC: 1917466.
DOI: 10.1111/j.1476-5381.1990.tb12072.x.
Evidence that 5-HT1A receptors are involved in the adrenaline-releasing effects of 8-OH-DPAT in the conscious rat.
Chaouloff F, Baudrie V, Laude D
Naunyn Schmiedebergs Arch Pharmacol. 1990; 341(4):381-4.
PMID: 1970616
DOI: 10.1007/BF00180665.
Lithium and 5-HT1A receptor sensitivity: a neuroendocrine study in healthy volunteers.
Walsh A, Ware C, Cowen P
Psychopharmacology (Berl). 1991; 105(4):568-72.
PMID: 1663254
DOI: 10.1007/BF02244382.